177 related articles for article (PubMed ID: 19661844)
61. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
[TBL] [Abstract][Full Text] [Related]
62. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
[TBL] [Abstract][Full Text] [Related]
63. Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI.
Romano A; Pasquini L; Di Napoli A; Tavanti F; Boellis A; Rossi Espagnet MC; Minniti G; Bozzao A
J Neurooncol; 2018 Sep; 139(2):455-460. PubMed ID: 29721752
[TBL] [Abstract][Full Text] [Related]
64. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
[TBL] [Abstract][Full Text] [Related]
65. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
66. Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer.
Himoto Y; Fujimoto K; Kido A; Matsumura N; Baba T; Daido S; Kiguchi K; Shitano F; Konishi I; Togashi K
Int J Gynecol Cancer; 2014 May; 24(4):751-7. PubMed ID: 24685827
[TBL] [Abstract][Full Text] [Related]
67. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer.
Soutter WP; Hanoch J; D'Arcy T; Dina R; McIndoe GA; DeSouza NM
BJOG; 2004 Jul; 111(7):741-7. PubMed ID: 15198766
[TBL] [Abstract][Full Text] [Related]
68. Volume computed tomography perfusion as a predictive marker for treatment response to concurrent chemoradiotherapy in cervical cancer: a prospective study.
Dong Rui T; Dong Y; Song Qing L; Tong R; Wang Fei F; Yu T; Luo Y
Acta Radiol; 2021 Feb; 62(2):281-288. PubMed ID: 32551871
[TBL] [Abstract][Full Text] [Related]
69. DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.
Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Wang MZ; Zhang H; Liang LH; Feng YN; Yang JH
Acad Radiol; 2020 Dec; 27(12):e263-e271. PubMed ID: 31983532
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients.
Tuncbilek N; Tokatli F; Altaner S; Sezer A; Türe M; Omurlu IK; Temizoz O
Eur J Radiol; 2012 May; 81(5):863-7. PubMed ID: 21398061
[TBL] [Abstract][Full Text] [Related]
71. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers.
Lee EY; Hui ES; Chan KK; Tse KY; Kwong WK; Chang TY; Chan Q; Khong PL
J Magn Reson Imaging; 2015 Aug; 42(2):454-9. PubMed ID: 25413245
[TBL] [Abstract][Full Text] [Related]
72. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.
Gui B; Valentini AL; Miccò M; D'Agostino GR; Tagliaferri L; Zannoni GF; Fanfani F; Manfredi R; Bonomo L
Acta Radiol; 2016 Sep; 57(9):1123-31. PubMed ID: 26622060
[TBL] [Abstract][Full Text] [Related]
73. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G
Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382
[TBL] [Abstract][Full Text] [Related]
74. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict chemotherapeutic responses and survival in primary central-nervous-system lymphoma.
Fu F; Sun X; Li Y; Liu Y; Shan Y; Ji N; Wang X; Lu J; Sun S
Eur Radiol; 2021 Apr; 31(4):1863-1871. PubMed ID: 32997181
[TBL] [Abstract][Full Text] [Related]
75. Predictive value of DCE-MRI for early evaluation of pathological complete response to neoadjuvant chemotherapy in resectable primary breast cancer: A single-center prospective study.
Sun YS; He YJ; Li J; Li YL; Li XT; Lu AP; Fan ZQ; Cao K; Ouyang T
Breast; 2016 Dec; 30():80-86. PubMed ID: 27652977
[TBL] [Abstract][Full Text] [Related]
76. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI.
Nam H; Park W; Huh SJ; Bae DS; Kim BG; Lee JH; Lee JW; Lim DH; Han Y; Park HC; Ahn YC
Gynecol Oncol; 2007 Nov; 107(2):320-5. PubMed ID: 17675222
[TBL] [Abstract][Full Text] [Related]
77. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
[TBL] [Abstract][Full Text] [Related]
78. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
79. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
[TBL] [Abstract][Full Text] [Related]
80. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
